Navigation Links
Using Product Marketing to Launch Drugs That Outperform the Competition
Date:1/17/2008

ts productive medical and marketing collaborations.

-- Top-performing benchmark partners conduct a wide spectrum of market

research, from pre-clinical to post-launch.

-- Leading companies spend gradually and selectively on high impact pre

marketing activities to create awareness, demand and preferences for

their new products.

To learn more about this study, review a complimentary report summary at http://www3.best-in-class.com/rr900.htm .

To drill down on the metrics and best practices presented in this report, contact Cameron Tew at 919-767-9246 or ctew@best-in-class.com .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www.best-in-class.com .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Holiday Visits Nudge Many Towards Senior Housing Decision
2. Researchers seek to make cavity-causing bacteria self-destruct
3. Winemaking waste proves effective against disease-causing bacteria in early studies
4. Novare Announces Completion of 100th Single Port Laparoscopic Procedure Using RealHand(R) High Dexterity (HD) Instruments
5. Using Early Stage Commercialization Activities to Build Long-Term Success for the Bottom Line
6. Reserve 2008 Budget for Using Quality to Improve the Customer Experience
7. Older Diabetics Using Avandia Face Increased Death Risk
8. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
9. UCSF Medical Center using newest high-tech tool for brain disorders
10. Mini transplant patients outcomes similar using related and unrelated donor cells
11. Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... State University College of Medicine research tea... new layer of regulation in the cell division cycl...the way cancer begins. , Wang, an assistant prof...icine, said the findings will lead to an improved ...esign of new drugs that kill cancer cells by inhib...
(Date:11/21/2008)...re-FirstCall/ -- Heska Corporation,(Nasdaq: HSK...k Society of,Security Analysts, 12th Annual Biote... 2008 at 1177 Avenue of the Americas, 2nd Floor in...egin at 9:35 a.m. Eastern Time (7:35 a.m.,Mountai... for two weeks,following the presentation through...
(Date:11/21/2008)...out future antibiotic resistance from widespread u...) -- People with moderate to severe chronic obstru...ce the frequency of exacerbations through a regula...ays. , The study, published in the first issue...ory and Critical Care Medicine , found that twice-...
(Date:11/21/2008)...swire/ -- The University of Texas M. D. Anderson...tive effort to eradicate breast cancer in Panama t... and Research of the Americas today at an event wi..., and Vivian Fernandez de Torrijos, the First Lady...he initiative are the U.S. Department of State and...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
...f ones appearance, their a large demand for slimmi...conducted in Belgium.// The survey also shows that...in value over 2004 to reach a retail value of €29 ...ve by both doctors and government authorities to i...
... New South Wales may be one of the first scientist...nd bipolar disease. Currently there is no single t... researchers who had their paper published in the ...ry Research said that this may make the diagnosis ...
...ime can reduce the chances of having a stroke from...archers from National Public Health Institute in H...he journal Stroke: Journal of the American Heart A...o the data provided by 47,721 people of Finland in...
...ages. So are the twin electroneedles, which is tar...to confirm heart attack episodes. The two arrays ...rating painlessly into the skin. Good thing come i...troneedles, which is targeted at diabetics and als...
Other Medicine News:Health News:With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising 2Health News:Schizophrenia Gets A New Diagnostic Tool 2Health News:Physical Activity During Leisure Can Reduce Risk Of Stroke 2Health News:Diabetes and heart attack diagnosis now made simple with twin magic 2
(Date:11/19/2008)...findings on critical enzyme,s regulation may hold ...of disorders , , MEMPHIS, Tenn., Nov. 19 /P...hildren,s Research Hospital have gained new insigh...khorses called calpains. , , As the cell,s...y cellular processes, including the movement of ce...
(Date:11/18/2008)... learn more, make a donation or send a Christmas S...wire-USNewswire/ -- Millions will receive Christma...erican Lung Association. These decorative holiday ... dating back to 1907 when the Lung Association led...st Americans alive today have no vivid memories of...
(Date:11/13/2008)...wswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ...of premium,diagnostics, medical imaging systems an...hcare needs of women, today announced the results ...al. The Cervista HPV high-risk,test is currently u... to be,launched in the European Union (EU) early i...
(Date:11/12/2008)...el, November 12 Surgeons,at the Un... that,patient-specific CTA data can be converted t...bionix US) with high face validity. The surgeons,"...operative flow,increased patient safety and effic...ve and fluoroscopy time and the amount of contrast...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues 16816 1Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues 16816 2Cynosure to Announce First Quarter 2008 Financial Results on April 29 16814 1Cynosure to Announce First Quarter 2008 Financial Results on April 29 16814 2Professor Woodpecker Makes Childrens Nutrition Fun and Simple 16812 1Professor Woodpecker Makes Childrens Nutrition Fun and Simple 16812 2Professor Woodpecker Makes Childrens Nutrition Fun and Simple 16812 3BioMS Medicals phase III U S multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 4603 1BioMS Medicals phase III U S multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 4603 2
...WIRE)--Mar 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), I...,today pre-clinical data from trials of BL-1040 de...g deterioration of the myocardium,after a myocardi...e,dilatation and eventual heart failure in a pig m... Neufeld Cardiac Research,Institute at Sheba Medic...
...ontrolled Study in Inoperable Chronic,Thromboembol...duction in Pulmonary Vascular Resistance Met - Six...n Dyspnoea Score and,Biological Disease Marker , ... Ltd (SWX:,ATLN) announced today the initial resul...icenter study BENEFiT (Bosentan Effects in,Inopera...
Other Medicine Technology:BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 2Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 3Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 4Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 5Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 6
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p
...stem (iQ200 Sprint) is a user-friendly, bench top,...nalyses on un-spun specimens; simply load and walk...y facility looking to reduce turnaround time. The ... per hour and with the optional Load/Unload Statio...
The PDM utilizes the latest technology for measuring interpupillary distance and left/right pupil-to-nose distance. Lightweight and easy-to-use, the PDM provides accurate and repeatable PD measuremen
VACUETTE® Tube Holders should be used exclusively with VACUETTE® Blood Collection Needles as both components are designed for optimal compatibility with one another.
Medicine Products: